Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors.

Beatriz Frade-SosaChafik Alejandro ChacurJosep M AugéAndrés PonceJuan C Sarmiento-MonroyAna Belén AzuagaNuria SapenaJulio RamírezVirginia Ruiz-EsquideRosa MorlàSandra FariettaPatricia CorzoJuan D CañeteRaimon SanmartíJosé A Gómez-Puerta

Published in: Cancers (2023)

the results suggest that calprotectin may serve as a marker of inflammatory activity in patients with rheumatic irAEs induced by treatment with ICIs.

Keyphrases